122 related articles for article (PubMed ID: 32194788)
21. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Wu M; Yuan H; Li X; Liao Q; Liu Z
Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
[No Abstract] [Full Text] [Related]
22. A Pre-operative Nomogram for Prediction of Lymph Node Metastasis in Bladder Urothelial Carcinoma.
Lu X; Wang Y; Jiang L; Gao J; Zhu Y; Hu W; Wang J; Ruan X; Xu Z; Meng X; Zhang B; Yan F
Front Oncol; 2019; 9():488. PubMed ID: 31293963
[TBL] [Abstract][Full Text] [Related]
23. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
[TBL] [Abstract][Full Text] [Related]
24. Development of a prognostic signature for bladder cancer based on immune-related genes.
Shi YR; Xiong K; Ye X; Yang P; Wu Z; Zu XB
Ann Transl Med; 2020 Nov; 8(21):1380. PubMed ID: 33313125
[TBL] [Abstract][Full Text] [Related]
25. Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma.
Zhou JG; Zhao HT; Jin SH; Tian X; Ma H
Gynecol Oncol; 2019 Dec; 155(3):499-507. PubMed ID: 31662204
[TBL] [Abstract][Full Text] [Related]
26. An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma.
Liu D; Zhou B; Liu R
PeerJ; 2020; 8():e9422. PubMed ID: 32742772
[TBL] [Abstract][Full Text] [Related]
27. Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data.
Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Front Oncol; 2020; 10():1257. PubMed ID: 32793502
[No Abstract] [Full Text] [Related]
28. Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma.
Ren H; Wu CR; Aimaiti S; Wang CF
Oncol Lett; 2020 Jun; 19(6):4093-4105. PubMed ID: 32382348
[TBL] [Abstract][Full Text] [Related]
29. Identification of Subtype-Specific Three-Gene Signature for Prognostic Prediction in Diffuse Type Gastric Cancer.
Bao B; Zheng C; Yang B; Jin Y; Hou K; Li Z; Zheng X; Yu S; Zhang X; Fan Y; Qu X; Liu Y; Che X
Front Oncol; 2019; 9():1243. PubMed ID: 31803620
[TBL] [Abstract][Full Text] [Related]
30. Radiomic signature of
Jiang Y; Yuan Q; Lv W; Xi S; Huang W; Sun Z; Chen H; Zhao L; Liu W; Hu Y; Lu L; Ma J; Li T; Yu J; Wang Q; Li G
Theranostics; 2018; 8(21):5915-5928. PubMed ID: 30613271
[TBL] [Abstract][Full Text] [Related]
31. Identification of a Six-Immune-Related Long Non-coding RNA Signature for Predicting Survival and Immune Infiltrating Status in Breast Cancer.
Li Z; Li Y; Wang X; Yang Q
Front Genet; 2020; 11():680. PubMed ID: 32733537
[TBL] [Abstract][Full Text] [Related]
32. Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma.
Liu XP; Yin XH; Meng XY; Yan XH; Wang F; He L
Front Oncol; 2018; 8():615. PubMed ID: 30671382
[No Abstract] [Full Text] [Related]
33. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.
Yuan Y; Ren J; Shi Y; Tao X
Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647
[TBL] [Abstract][Full Text] [Related]
34. LASSO‑based Cox‑PH model identifies an 11‑lncRNA signature for prognosis prediction in gastric cancer.
Zhang Y; Li H; Zhang W; Che Y; Bai W; Huang G
Mol Med Rep; 2018 Dec; 18(6):5579-5593. PubMed ID: 30365077
[TBL] [Abstract][Full Text] [Related]
35. A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer.
Chen S; Zhang N; Shao J; Wang T; Wang X
J Cancer; 2019; 10(23):5744-5753. PubMed ID: 31737111
[No Abstract] [Full Text] [Related]
36. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
[TBL] [Abstract][Full Text] [Related]
37. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of lncRNAs-based nomogram for prediction of biochemical recurrence in prostate cancer by bioinformatics analysis.
Shao N; Tang H; Qu Y; Wan F; Ye D
J Cancer; 2019; 10(13):2927-2934. PubMed ID: 31281469
[No Abstract] [Full Text] [Related]
39. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
40. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma.
Chen W; Ou M; Tang D; Dai Y; Du W
J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
